| GO term | Total | Expected | Hits | val |
| Negative regulation of signal transduction | 790 | 1.27 | 6 (RHOA, ARRB1, MYC, THBS1, PHLDA3, and STK4) | 0.00126 | Response to carbohydrate stimulus | 143 | 0.23 | 3 (RHOA, ARRB1, and THBS1) | 0.0015 | Response to drug | 344 | 0.554 | 4 (RHOA, MYC, THBS1, and PFAS) | 0.00204 | Notch signaling pathway | 177 | 0.285 | 3 (ARRB1, MYC, and AGO2) | 0.00276 | Cell-cell junction organization | 186 | 0.299 | 3 (RHOA, CDH6, and THBS1) | 0.00317 | Regulation of binding | 189 | 0.304 | 3 (ARRB1, THBS1, and SUMO1) | 0.00332 | Negative regulation of response to stimulus | 967 | 1.56 | 6 (RHOA, ARRB1, MYC, THBS1, PHLDA3, and STK4) | 0.00352 | Positive regulation of translation | 56 | 0.0901 | 2 (RHOA, THBS1) | 0.00362 | Negative regulation of myeloid cell differentiation | 60 | 0.0966 | 2 (MYC, TOB2) | 0.00415 | Transforming growth factor beta receptor signaling pathway | 221 | 0.356 | 3 (RHOA, MYC, and THBS1) | 0.00514 | Regulation of translation | 228 | 0.367 | 3 (RHOA, THBS1, and AGO2) | 0.00561 |
|
|